Applying Real World Evidence to Patient Care: NOAC Therapy for Atrial Fibrillation

Applying Real World Evidence to Patient Care: NOAC Therapy for Atrial Fibrillation is organized by Pri-Med.

Effective Date: 9/30/2019.
Expiration Date: 9/30/2020.

Credits:
• 1.00 AMA PRA Category 1 Credits™
• 1.00 AANP, including 0.38 AANP Pharm
• 1.00 ABIM MOC

Topics:
Atrial Fibrillation, Cardiovascular Medicine

Overview:
Evidence from real world studies on the effectiveness, safety, and dosing of non-vitamin-K oral anticoagulants (NOACs) provides crucial insights on the treatment of patients with atrial fibrillation (AF). In this program, you will learn to assess the quality of these studies and compare the relevance, validity, and utility of the results to those of randomized controlled trials. Judicial assessment and appropriate incorporation of real world data into clinical practice can improve the care of your patients with AF and other conditions.

Learning Objectives:
• Explain the differences between RCTs and real world studies, including the study setting, type of data being evaluated, and utility of the results
• Describe RWD methodology and assess the quality of real world studies to determine their relevance and usefulness in clinical practice
• Describe recent real world studies about NOAC effectiveness, safety, and dosing, and recognize how these studies can inform clinical care 

Additional details will be posted as soon as information is available.